owens & minor inc. - OMI

OMI

Close Chg Chg %
3.16 -0.33 -10.46%

Closed Market

2.83

-0.33 (10.46%)

Volume: 3.46M

Last Updated:

Dec 19, 2025, 3:59 PM EDT

Company Overview: owens & minor inc. - OMI

OMI Key Data

Open

$3.21

Day Range

2.82 - 3.21

52 Week Range

2.38 - 15.53

Market Cap

$243.64M

Shares Outstanding

77.35M

Public Float

74.37M

Beta

1.36

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$17.40

Yield

0.00%

Dividend

$0.00

EX-DIVIDEND DATE

Dec 14, 2021

SHORT INTEREST

N/A

AVERAGE VOLUME

1.95M

 

OMI Performance

1 Week
 
4.65%
 
1 Month
 
17.10%
 
3 Months
 
-39.89%
 
1 Year
 
-74.84%
 
5 Years
 
-89.00%
 

OMI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

About owens & minor inc. - OMI

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.

OMI At a Glance

Owens & Minor, Inc.
10900 Nuckols Road
Henrico County, Virginia 23060
Phone 1-804-723-7000 Revenue 10.70B
Industry Medical Specialties Net Income -362,686,000.00
Sector Health Technology 2024 Sales Growth 3.551%
Fiscal Year-end 12 / 2025 Employees 23,200
View SEC Filings

OMI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.094
Price to Book Ratio 1.785
Price to Cash Flow Ratio 6.21
Enterprise Value to EBITDA 6.052
Enterprise Value to Sales 0.298
Total Debt to Enterprise Value 0.701

OMI Efficiency

Revenue/Employee 461,244.957
Income Per Employee -15,633.017
Receivables Turnover 15.461
Total Asset Turnover 2.195

OMI Liquidity

Current Ratio 1.079
Quick Ratio 0.475
Cash Ratio 0.026

OMI Profitability

Gross Margin 18.264
Operating Margin 2.444
Pretax Margin -3.34
Net Margin -3.389
Return on Assets -7.44
Return on Equity -48.703
Return on Total Capital -12.97
Return on Invested Capital -12.733

OMI Capital Structure

Total Debt to Total Equity 394.715
Total Debt to Total Capital 79.786
Total Debt to Total Assets 47.916
Long-Term Debt to Equity 370.517
Long-Term Debt to Total Capital 74.895
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Owens & Minor Inc. - OMI

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
9.79B 9.96B 10.33B 10.70B
Sales Growth
+15.39% +1.74% +3.80% +3.55%
Cost of Goods Sold (COGS) incl D&A
8.36B 8.36B 8.50B 8.75B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
90.62M 228.67M 287.38M 264.77M
Depreciation
40.51M 135.82M 170.24M 182.78M
Amortization of Intangibles
50.11M 92.85M 117.14M 82.00M
COGS Growth
+14.67% -0.06% +1.66% +2.95%
Gross Income
1.42B 1.60B 1.84B 1.95B
Gross Income Growth
+19.80% +12.31% +15.03% +6.34%
Gross Profit Margin
+14.54% +16.05% +17.78% +18.26%
2021 2022 2023 2024 5-year trend
SG&A Expense
1.03B 1.41B 1.63B 1.71B
Research & Development
- - - -
-
Other SG&A
1.03B 1.41B 1.63B 1.71B
SGA Growth
+8.25% +36.91% +15.82% +5.09%
Other Operating Expense
- - - (17.12M)
-
Unusual Expense
48.99M 55.02M 95.61M 457.04M
EBIT after Unusual Expense
347.37M 137.66M 114.96M (195.55M)
Non Operating Income/Expense
(22.52M) 1.47M (2.05M) (10.17M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
48.09M 128.24M 167.63M 151.63M
Interest Expense Growth
-35.16% +166.67% +30.72% -9.55%
Gross Interest Expense
48.09M 128.24M 167.63M 151.63M
Interest Capitalized
- - - -
-
Pretax Income
276.75M 10.89M (54.73M) (357.36M)
Pretax Income Growth
+151.81% -96.06% -602.49% -552.99%
Pretax Margin
+2.83% +0.11% -0.53% -3.34%
Income Tax
55.16M (11.50M) (13.43M) 5.33M
Income Tax - Current - Domestic
70.05M 6.21M 5.42M 26.22M
Income Tax - Current - Foreign
14.85M 8.65M 4.89M 5.22M
Income Tax - Deferred - Domestic
(26.22M) (14.07M) (22.90M) (25.72M)
Income Tax - Deferred - Foreign
(3.52M) (12.29M) (829.00K) (393.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
221.59M 22.39M (41.30M) (362.69M)
Minority Interest Expense
- - - -
-
Net Income
221.59M 22.39M (41.30M) (362.69M)
Net Income Growth
+151.59% -89.90% -284.47% -778.15%
Net Margin Growth
+2.26% +0.22% -0.40% -3.39%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
221.59M 22.39M (41.30M) (362.69M)
Preferred Dividends
- - - -
-
Net Income Available to Common
221.59M 22.39M (41.30M) (362.69M)
EPS (Basic)
3.0462 0.3005 -0.545 -4.7261
EPS (Basic) Growth
+546.20% -90.14% -281.36% -767.17%
Basic Shares Outstanding
72.74M 74.50M 75.78M 76.74M
EPS (Diluted)
2.9355 0.2938 -0.545 -4.7261
EPS (Diluted) Growth
+524.18% -89.99% -285.50% -767.17%
Diluted Shares Outstanding
75.49M 76.22M 75.78M 76.74M
EBITDA
486.98M 421.35M 497.94M 526.26M
EBITDA Growth
+46.31% -13.48% +18.18% +5.69%
EBITDA Margin
+4.98% +4.23% +4.82% +4.92%

Snapshot

Average Recommendation HOLD Average Target Price 5.70
Number of Ratings 6 Current Quarters Estimate 0.227
FY Report Date 12 / 2025 Current Year's Estimate 1.02
Last Quarter’s Earnings 0.25 Median PE on CY Estimate N/A
Year Ago Earnings 1.53 Next Fiscal Year Estimate 0.972
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 2 6 6
Mean Estimate 0.23 0.15 1.02 0.97
High Estimates 0.25 0.16 1.06 1.14
Low Estimate 0.22 0.15 0.95 0.82
Coefficient of Variance 5.38 6.19 3.63 10.48

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 2
OVERWEIGHT 1 1 1
HOLD 2 2 1
UNDERWEIGHT 1 1 1
SELL 1 1 1
MEAN Hold Hold Hold

Insider Actions for Owens & Minor Inc. - OMI

Date Name Shares Transaction Value
Nov 21, 2025 Andrew G. Long EVP, CEO P&HS 214,064 Bona fide gift 0.00
May 21, 2025 Heath H. Galloway EVP,General Counsel & CorpSecy 117,044 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $7.38 per share 863,784.72
Apr 8, 2025 Coliseum Capital Management LLC 10,784,599 Open market or private purchase of non-derivative security Non-derivative transaction at $8.53 per share 91,992,629.47
Apr 8, 2025 Coliseum Capital Management LLC 10,912,955 Open market or private purchase of non-derivative security Non-derivative transaction at $8.14 per share 88,831,453.70
Apr 8, 2025 Coliseum Capital Management LLC 11,152,955 Open market or private purchase of non-derivative security Non-derivative transaction at $7.84 per share 87,439,167.20
Mar 25, 2025 Edward A. Pesicka President & CEO; Director 1,184,630 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.09 per share 11,952,916.70
Mar 25, 2025 Jonathan A. Leon EVP & CFO 225,428 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.09 per share 2,274,568.52
Mar 25, 2025 Michael Wayne Lowry SVP, Corporate Controller 123,454 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.09 per share 1,245,650.86
Mar 25, 2025 Perry A. Bernocchi EVP, CEO,. Patient Direct 247,360 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.09 per share 2,495,862.40
Mar 25, 2025 Snehashish Sarkar 112,922 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.09 per share 1,139,382.98
Mar 6, 2025 Jennifer Stone EVP, CHRO 116,091 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Owens & Minor Inc. in the News